EUPHORIA presented by iThera Medical’s Tim Devling at Tel-Aviv U IBD Research Seminar

Tim Devling, Director of Sales and Applications at iThera Medical gave a talk entitled “Latest Advances in Clinical Imaging of Crohn’s Disease” on Wednesday, May 19th, 2021, International IBD Awareness Day at The 2nd Tel-Aviv University Inflammatory Bowel Diseases Research Seminar. Tim’s talk highlighted the EUPHORIA Project and the latest MSOT technological advances.

The online meeting attracted a mix of sixty clinicians and academic researchers. See the meeting programme here.

By euphoria_admin|2021-06-02T08:30:07+01:00June 2nd, 2021|

Your privacy

We use cookies to improve your experience on this website. We never show advertisements, but do share content from third-parties (e.g. videos). Data about your interaction with the site is used to improve the content that we share.

You can change your mind at any time by updating your settings. Please let us know if you agree.
Cookie Settings Accept

Tracking Cookies

We use Google Analytics to help us improve our website by collecting information on how you use this site. The cookies collect information without directly identifying you. You can read more about our use of Google Analytics on our Privacy Policy.

Tracking Cookies

Third Party Embeds

Pages on this site may include embedded content (e.g. YouTube videos). Embedded content behaves in the same way as if a user had visited that site and these websites may collect data about you. To learn more please visit our Privacy Policy.

YouTube
X

Necessary

Necessary cookies help make a website usable by enabling basic functions. The website cannot function properly without these cookies. You may disable these by changing your browser settings but this will affect how the website functions.

Our Privacy Policy

We respect your privacy. Our site uses several third-party services. Please select which cookies you would like to allow by selecting the checkboxes. To learn more or update your settings please visit our Privacy Policy. Thank you.